Experimental model of short-time exercise-induced preconditioning in POAD patients

Angiology

Volumn 48, Issue 6, 1997, Pages 469-480

  Capecchi, Pier Leopoldo ^a   Pasini, Franco Laghi ^a   Cati, Graziella ^a   Colafati, Marcella ^a   Acciavatti, Angela ^a   Ceccatelli, Linda ^a   Petri, Biold Silvia ^a   De Lalla, Arianna ^a   Di Perri, Tullio ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE;

ADULT; AGED; ARTICLE; BLOOD RHEOLOGY; CLINICAL ARTICLE; CONDITIONING; CONTROLLED STUDY; FEMALE; HUMAN; KINESIOTHERAPY; MALE; NEUTROPHIL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICAL ACTIVITY; TREADMILL EXERCISE; WALKING;

EID: 0030988665     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979704800601     Document Type: Article

References (51)

1. Larsen OA, Lassen NA: Effect of daily muscular exercise in patients with intermittent claudication. Lancet 2:1093-1095, 1966.
2. Ericson B, Haeger K, Lindell SE: Effect of physical training on intermittent claudication. Angiology 21:188-192, 1970.
3. Mannarino E, Pasqualini L, Menna M, et al: Effect of physical training on peripheral vascular disease: A controlled study. Angiology 40:5-10, 1989.
4. Hiatt WR, Regensteiner JG, Harganten ME, et al: Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation 81:602-609, 1990.
5. Hiatt WR, Wolfel EE, Meier RH, et al: Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Circulation 90:1866-1874, 1994.
6. Di Perri T, Laghi Pasini F, Ralli L, et al: Effect of controlled physical activity on hemorheologic and metabolic changes in POAD patients. Clin Hemorheol 8:737-750, 1988.
7. Poulin MJ, Paterson DH, Govindasamy D, et al: Endurance training of older men: Responses to sub-maximal exercise. J Appl Physiol 73:452-457, 1992.
8. Gardner AW, Skinner JS, Kent Smith L: Effects of handrail support on claudication and hemodynamic responses in single-stage and progressive treadmill protocols in peripheral vascular occlusive disease. Am J Cardiol 68:99-105, 1991.
9. Lundgren F, Dahllof AG, Lundholm K, et al: Intermittent claudication - surgical reconstruction or physical training? A prospective randomized trial of treatment efficacy. Ann Surg 209:346-355, 1989.
10. Sanne H, Silversson R: The effect of exercise on the development of collateral circulation after experimental occlusion of the femoral artery in the cat. Acta Physiol Scand 73:257-263, 1968.
11. Schoop W: Mechanism of beneficial action of daily walking training of patients with intermittent claudication. Scand J Clin Invest 128(suppl):197-200, 1973.
12. Waibel PP, Wolff G: The collateral circulation in occlusion of the femoral artery: An experimental study. Surgery 60:912-916, 1966.
13. Weiss T, Fujita Y, Kreimeier U, et al: Effect of intensive walking exercise on skeletal muscle blood flow in intermittent claudication. Angiology 43:63-70, 1992.
14. Ernst EE, Matrai A: Intermittent claudication, exercise, and blood rheology. Circulation 76:1110-1114, 1987.
15. Mokken FC, Kedaria M, Henny CP, et al: The clinical importance of erythrocyte deformability, a hemorheologic parameter. Ann Hematol 64:113-122, 1992.
16. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136, 1986.
17. Scott RJ, Rohmann S, Braun ER, et al: Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 66:1133-1142, 1990.
18. Li GC, Vasquez JA, Gallagher KP, et al: Myocardial protection with preconditioning. Circulation 82:609-619, 1990.
19. Liu GS, Thornton JD, Van Winkle DM, et al: Protection against infarction afforded by preconditioning is mediated by Al adenosine receptors in rabbit heart. Circulation 84:350-356, 1991.
20. Thornton JD, Liu GS, Olsson RA, et al: Intravenous preteatment with A1-selective adenosine analogues protects the heart against infarction. Circulation 85:659-665, 1992.
21. Mosca SA, Gelpi RJ, Cingolani HE: Adenosine and dipyridamole mimic the effects of ischemic preconditioning. J Mol Cell Cardiol 26:1403-1409, 1994.
22. Pearson JD, Gordon JL: Vascular endothelial and smooth muscle cells in culture selectively release adenine nucleotides. Nature 281:384-386, 1979.
23. Bardenheuer H, Schrader J: Relationship between myocardial oxygen consumption, coronary flow, and adenosine release in an improved isolated heart preparation of guinea pig. Circ Res 51:263-271, 1983.
24. Bardenheuer H, Schrader J: Supply-to-demand ratio for oxygen determines formation of adenosine in the heart. Am J Physiol 250:H113-H118, 1986.
25. Borst MM, Schrader J: Adenine nucleotide release from isolated perfused guinea pig hearts and extra-cellular formation of adenosine. Circ Res 68:797-806, 1991.
26. Di Perri T, Laghi Pasini F: Fisiopatologia e farmacologia del sistema adenosinico. Proceedings of the 92nd Congress of the Italian Society of Internal Medicine. Rome, October 15-19, 1991, Luigi Pozzi, ed. Rome, 1-233, 1991.
27. Berne RM: Cardiac nucleotides in hypoxia: Possible role in the regulation of coronary blood flow. Am J Physiol 204:317-322, 1963.
28. Sollevi A: Cardiovascular effects of adenosine in man: Possible clinical implications. Prog Neurobiol 27:319-349, 1986.
29. Gruber TN: Increased adenosine concentration in blood from ischemic myocardium by AICA riboside: Effects on flow, granulocyte and injury. Circulation 80:1400-1411, 1983.
30. Pitarys CJ II, Virmiani R, Vildbill HDJr, et al: Reduction of myocardial reperfusion injury by intra-venous adenosine administered during the early reperfusion period. Circulation 83:237-247, 1991.
31. Haslam RJ, Rosson GM: Effects of adenosine on adenosine cyclic 3′,5′-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation. Mol Pharmacol 11:528-544, 1975.
32. Di Perri T, Laghi Pasini F, Pecchi S, et al: In vivo and in vitro evidence of an adenosine-mediated mechanism of calcium entry blocker activities. Angiology 40:190-198, 1989.
33. Boyenaems JM, Pirroton S, Demolle D, et al: Adenine nucleotides and endothelium. In: The Endothelium: An Introduction to Current Research, ed. by Warren JB. New York: Wiley Liss, 1990, pp 53-63.
34. Fox IH: Adenosine triphosphate degradation in specific disease. J Lab Clin Med 106:101-110, 1985.
35. Laghi Pasini F, Frigerio C, De Giorgi L, et al: Effect of adenosine i.v. infusion on peripheral hemodynamics, hemorheology and platelet behavior in man. Clin Hemorheol 14:709-722, 1994.
36. Capecchi PL, Ceccatelli L, Petri S, et al: Buflomedil prevents ischemia-dependent changes in blood rheology and neutrophil reactivity: A possible adenosine-mediated mechanism. Clin Hemorheol 15:221-223, 1995.
37. Newby AC, Wiorku CY, Holmquist CA: Adenosine formation: Evidence for a direct biochemical link with energy metabolism. Adv Myocardiol 6:273-284, 1985.
38. Owall A, Sollevi A, Rudehill A, et al: Effect of adenosine-induced controlled hypotension on canine myocardial performance, blood flow and metabolism. Acta Anaesth Scand 30:167-172, 1986.
39. Reid HS, Barnes AJ, Lock PJ, et al: A simple method for measuring erythrocyte deformability. J Clin Pharmacol 29:855-858, 1976.
40. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450, 1985.
41. Conen MV, Liu GS, Downey JM: Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbit. Circulation 84:341-349, 1991.
42. Grover GJ, Sleph PG, Dzwonczyk S: Role of myocardial ATP-sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine A1-receptor. Circulation 86:1310-1316, 1992.
43. Blardi P, Laghi Pasini F, Urso R, et al: Pharmacokinetics of exogenous adenosine in man after infusion. Eur J Clin Pharmacol 44:505-507, 1993.
44. Dendorfer A, Lauk S, Schaff A, et al: In: Uric Acid, the Major Catabolite of Cardiac Adenine Nucleotides and Adenosine, Originated in the Coronary Endothelium, ed. by Gerlach E, Becker BF. Berlin: Springer Verlag, 1987, pp 199-209.
45. Kitakaze M, Hori M, Takashima S, et al: Ischemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in the dog. Implications for myocardial salvage. Circulation 87:208-215, 1993.
46. Lasley RD, Rhee JW, Van Wylen GL, et al: Adenosine A1-receptor mediated protection of the globally ischemic isolated rat heart. J Mol Cell Cardiol 22:39-47, 1990.
47. Deutsch E, Berger M, Kussmaul WG, et al: Adaptation to ischemia during percutaneous transluminal coronary angioplasty: Clinical hemodynamic and metabolic features. Circulation 82:2044-2051, 1990.
48. Ottani F, Galvani M, Ferrini D, et al: Prodromal angina limits infarct size. A role for ischemic preconditioning. Circulation 91:291-297, 1995.
49. Sack S, Mohri M, Arras M, et al: Ischemic preconditioning-time course of renewal in the pig. Cardiovasc Res 27:551-555, 1993.
50. Yang X-M, Arnoult S, Tsuchida A: The protection of ischemic preconditioning can be reinstated in the rabbit heart after the initial protection has waned. Cardiovasc Res 27:556-558, 1993.
51. Mentzner R Jr: Metabolic and receptor-mediated effects of adenosine in the ischemic heart. Abstract Book of the 5th International Symposium on Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology. Philadelphia, PA, USA, May 9-13, 1994.